How many insider declarations has Mr. Narsimha Shibroor Kamath filed?

Mr. Narsimha Shibroor Kamath has filed 3 public insider declarations with SEBI (PIT + SAST).

What is Mr. Narsimha Shibroor Kamath's role?

Mr. Narsimha Shibroor Kamath's reported role is not specified by the regulator across the filings.

Which companies does Mr. Narsimha Shibroor Kamath report trades for?

Mr. Narsimha Shibroor Kamath reports trades for Bliss GVS Pharma Limited.

← Executives ★ Sign in to follow

MN

Mr. Narsimha Shibroor Kamath

·SEBI (PIT + SAST)

Bliss GVS Pharma Limited

累计流向

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

Discover the complete record of transactions filed by Mr. Narsimha Shibroor Kamath. Director active across 1 company, notably Bliss GVS Pharma Limited. Aggregated, 3 filings have been logged. History available since 24 February 2023. The latest transaction was filed on 18 February 2025 (Purchase). Regulator: SEBI (PIT + SAST). All data is openly available.

Companies and markets linked to Mr. Narsimha Shibroor Kamath

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Bliss GVS Pharma Limited (IN)IN insider transactions · SEBI (PIT + SAST)

申报3 总计

●

Mr. Narsimha Shibroor Kamath

高管2025年2月19日Bliss GVS Pharma Limited

₹307万3SEBI ↗

23,000 股@ ₹133.59248.2% 占其流量Equity SharesSEBI:5fcb662d6225032ea1009ee5c7a1b981c368abae

●

Mr. Narsimha Shibroor Kamath

高管2025年2月18日Bliss GVS Pharma Limited

₹982万5SEBI ↗

77,000 股@ ₹127.523326.1% 占其流量Equity SharesSEBI:eb1ced4652a904a6a486263d514c7adae68b9b1e

●

Mr. Narsimha Shibroor Kamath

高管2023年2月24日Bliss GVS Pharma Limited

₹2372万9SEBI ↗

300,000 股@ ₹79.082465.7% 占其流量Equity SharesSEBI:797c22b71c87360112ec722c7a5d4ba340eb0e82

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

MN

Mr. Narsimha Shibroor Kamath

·SEBI (PIT + SAST)

Bliss GVS Pharma Limited

累计流向

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

Discover the complete record of transactions filed by Mr. Narsimha Shibroor Kamath. Director active across 1 company, notably Bliss GVS Pharma Limited. Aggregated, 3 filings have been logged. History available since 24 February 2023. The latest transaction was filed on 18 February 2025 (Purchase). Regulator: SEBI (PIT + SAST). All data is openly available.